RenovoRx, Inc.
RNXT institutional ownership changes in Q2 2026: 7 institutions opened or added positions, 8 trimmed or exited. RNXT (RenovoRx, Inc.) is held by 18 institutional investors as of Q2 2026. Top institutional shareholders: Vanguard Capital Management LLC ($1.4M), Geode Capital Management, LLC ($415,687), Wealthspire Advisors, LLC ($247,475). Institutions were selling, on balance.
Who's Trading
Latest move
Source dates: Price Nov 6, 2026 · Insiders Sep 15, 2026 · Activists Nov 6, 2026 · Congress none
Top Holders
| Action | ||||||
|---|---|---|---|---|---|---|
Decreased | 1.4M(-0.2%) | $1.4M | 0.0% | +11.88% | 0 | |
Increased | 424,148(+11.1%) | $415,687 | 0.0% | — | 18 | |
Unchanged | 252,525 | $247,475 | 0.0% | +34.52% | 0 | |
Increased | 240,330(+52.2%) | $235,523 | 0.0% | +13.03% | 32 | |
Decreased | 133,597(-42.6%) | $130,925 | 0.0% | +5.64% | 0 | |
Increased | 85,207(+102.1%) | $83,503 | 0.0% | +9.13% | 24 | |
Decreased | 74,596(-25.0%) | $73,104 | 0.0% | -8.78% | 0 | |
Increased | 46,399(+92.2%) | $45,471 | 0.0% | +5.39% | 22 | |
Unchanged | 35,520 | $34,810 | 0.0% | -7.55% | 0 | |
Decreased | 29,983(-1.7%) | $29,383 | 0.0% | +1.70% | 0 | |
Unchanged | 26,152 | $25,629 | 0.0% | — | 0 | |
Increased | 20,820(+523.7%) | $20,404 | 0.0% | +16.18% | 21 | |
Unchanged | 20,000 | $19,600 | 0.0% | +14.14% | 0 | |
Increased | 19,000(+5.6%) | $18,620 | 0.0% | +24.18% | 13 | |
Unchanged | 12,307 | $12,061 | 0.0% | -14.07% | 0 | |
Decreased | 11,400(-12.3%) | $11,172 | 0.0% | -13.34% | 0 | |
Unchanged | 7,102 | $6,960 | 0.0% | +14.93% | 0 | |
New | 1,151 | $1,128 | 0.0% | +59.18% | 17 | |
Exited | 0(-100.0%) | $43,000 | 0.0% | -9.59% | 0 | |
Exited | 0(-100.0%) | $3,956 | 0.0% | -2.98% | 0 |
Showing 1-20 of 21
| Insider | Trade | Traded |
|---|---|---|
| VOLL MARK | Vest 80K sh | |
| VOLL MARK | Buy $20K | |
| VOLL MARK | Vest 80K sh | |
| VOLL MARK | Vest 12K sh | |
| Bagai Shaun | Buy | |
| VOLL MARK | Buy | |
| RYAN UNA S | Other 16K sh | |
| RYAN UNA S | Other 27K sh | |
| RYAN UNA S | Other 6K sh | |
| RYAN UNA S | Other 48K sh |
| Filer | Stake | Filed |
|---|---|---|
| BOSTON SCIENTIFIC CORP | 0.0% | |
| Orin Hirschman | 9.8% | |
| AWM Investment Company, Inc. | 2.4% |
RNXTRenovoRx, Inc.Continue exploring
Other Healthcare stocks held by institutions
UNHUnitedHealth Group Incorporated
LLYEli Lilly and Company
TMOThermo Fisher Scientific Inc
JNJJohnson & Johnson
DHRDanaher Corporation
ISRGIntuitive Surgical, Inc.
MRKMerck & Company, Inc.
ABBVAbbVie Inc.
BSXBoston Scientific Corporation
ABTAbbott LaboratoriesQuestions investors ask about RNXT
Who owns RNXT?
18 institutional investors held RNXT on June 30, 2026, led by Vanguard Capital Management LLC ($1.4M), Geode Capital Management, LLC ($415,687) and Wealthspire Advisors, LLC ($247,475).
How many hedge funds hold RNXT?
18 institutional investors reported RNXT in their 13F filings for the quarter ended June 30, 2026, $2.8M in all. One of them is rated Elite.
Are institutions buying or selling RNXT?
Selling, on balance. In Q2 2026, 8 institutions trimmed or exited RNXT and 7 institutions opened or added to positions.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer